The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Harmony Biosciences Holdings's share price is $30.795.
Harmony Biosciences Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $10.40. Hence, Harmony Biosciences Holdings's PS Ratio for today is 2.96.
The historical rank and industry rank for Harmony Biosciences Holdings's PS Ratio or its related term are showing as below:
HRMY'
s PS Ratio Range Over the Past 10 Years
Min: 2.16 Med: 7.34 Max: 41.25
Current: 3
During the past 6 years, Harmony Biosciences Holdings's highest PS Ratio was 41.25. The lowest was 2.16. And the median was 7.34.
HRMY's PS Ratio is ranked better than 77.41% of 996
companies
in the Biotechnology industry
Industry Median: 9.14
vs HRMY: 3.00
During the past 6 years, Harmony Biosciences Holdings's highest 3-Year average Revenue per Share Growth Rate was 304.90% per year. The lowest was 15.90% per year. And the median was 160.40% per year.
Back to Basics: PS Ratio
Harmony Biosciences Holdings PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Harmony Biosciences Holdings's PS Ratio
For the Biotechnology subindustry, Harmony Biosciences Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Harmony Biosciences Holdings's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Harmony Biosciences Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Harmony Biosciences Holdings's PS Ratio falls into.
Harmony Biosciences Holdings PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Harmony Biosciences Holdings's Share Price of today is $30.795. Harmony Biosciences Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.40.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Harmony Biosciences Holdings (NAS:HRMY) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Harmony Biosciences Holdings PS Ratio Related Terms
Thank you for viewing the detailed overview of Harmony Biosciences Holdings's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Harmony Biosciences Holdings (Harmony Biosciences Holdings) Business Description
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HRMY has been successfully added to your 